The Food Allergy Collaborative — a consortium of nonprofits serving the food allergy community — invites you to attend the Externally-led Patient-Focused Drug Development meeting for food allergy where patients will share their lived experience managing and treating food allergy with FDA representatives.
Tune in on their streaming platform to hear patient testimonies to the FDA and submit your feedback during the open discussion portion of the meeting.
Date/Time: September 9, 2021 10:00AM – 03:30PM EDT
Session 1 – Symptoms and Daily Impacts of Food Allergy
Topics will include:
- What are the biggest challenges of having a food allergy?
- How does having a food allergy impact your daily life and mental health?
Session 2 – Patients’ Perspectives on Prevention and Treatments for Food Allergy
Topics will include:
- What challenges or barriers to epinephrine access have you encountered?
- Are you/your child currently undergoing treatment for your food allergy?
Click here to register to live-stream the PFDD meeting on September 9. A viewing link will be sent before the meeting.
Want to learn more about the Externally-led Patient Focused Drug meeting?
The following webinar provides an overview of the US Food & Drug Administration (FDA) and the process of drug development. It will explain the purpose of Patient-Focused Drug Development and why it is important for the food allergy community:
